Bayforest Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,424
Closed -$423K 775
2025
Q1
$423K Buy
+12,424
New +$423K 0.18% 195